Active solutions for temperature-controlled, pharmaceutical air cargo are proven to be more effective in every way. They reduce risk in a hazardous world, cut costs when economies are struggling and boost sustainability at a time when the globe is desperately trying to minimise emissions.
Yet barriers to their adoption remain. It should be a simple decision to begin using them, so why does reticence exist? The answer is complex and perhaps as much to do with human nature as it is rational decision-making.
This paper explores barriers to adoption and suggests ways to overcome them.
Fill in the form below you so we can send you the white paper by email.